MIAMI, FL - May 16, 2024 - Blue Clay Health, a pioneering healthcare technology company, today announced the formation of its Advisory Board, bringing together a group of renowned experts and visionaries to guide the company's mission of revolutionizing care for patients with complex medical conditions. The Advisory Board will play a pivotal role in shaping Blue Clay Health's strategy, driving innovation, and ensuring the company remains at the forefront of healthcare transformation.
The Blue Clay Health Advisory Board members include:
Dana DiFerdinando, Former Chief Data Officer at GE Healthcare, recognized for her expertise in leveraging data and technology to drive healthcare innovation.
Dr. Garth Graham, Director and Global Head of Healthcare and Public Health at Google Health/YouTube, renowned for his leadership in advancing public health initiatives.
Guadalupe Hayes-Mota, a respected entrepreneur, MIT professor, and leader in healthcare innovation, known for his work in biotechnology and healthcare policy.
Sharon Higgins, Chair of the National Board of Trustees for the March of Dimes, celebrated for her tireless advocacy for maternal and infant health.
Mei Jiang, Founder & CEO at Stealth Startup, former SVP and Global Head of Digital Innovation & Commercialization at Medtronic, visionary tech entrepreneur and digital trailblazer, recognized for her transformative work in healthcare innovation and market creation.
Dr. Sandra Stratford, a distinguished physician executive and Trustee at the Dana-Farber Cancer Institute, former Chief Medical Officer at Raytheon, renowned for her contributions to healthcare strategy and innovation in the employer space.
Jenni Vargas, an acclaimed healthcare strategy expert, known for her impactful leadership roles at organizations such as One Medical and Stanford Health Care.
"We are honored to have such an exceptional group of leaders join our Advisory Board," said Chris Riley, Founder and CEO of Blue Clay Health. "Their collective expertise, insights, and commitment to improving healthcare outcomes will be invaluable as we work to break down barriers, foster global collaboration, and leverage cutting-edge technology to transform care for patients with complex medical conditions."
"Having experienced firsthand the challenges of navigating a fragmented healthcare system, I am deeply committed to Blue Clay Health's mission," said Chris Riley. "Our Advisory Board shares this dedication, and together, we will work tirelessly to ensure that patients with complex medical needs receive the highest quality care, irrespective of geographic constraints."
The formation of the Advisory Board marks a significant milestone for Blue Clay Health as the company prepares to launch this summer. By leveraging the collective wisdom and expertise of its advisors, Blue Clay Health is well-positioned to drive meaningful change in the healthcare industry and improve outcomes for patients and families facing the most challenging medical circumstances.
For more information about Blue Clay Health and its Advisory Board, please visit www.blueclayhealth.com.
About Blue Clay Health
Blue Clay Health is a healthcare technology company dedicated to revolutionizing care for patients with complex medical conditions. By combining cutting-edge technology with a patient-centered approach, Blue Clay Health empowers patients, families, and healthcare providers to collaborate seamlessly and access the best possible care, regardless of location. The company's flagship offering, the Ensemble Care Hub, is a groundbreaking platform that leverages technology and advanced analytics to streamline care coordination, enable secure data sharing, and improve patient outcomes.
Contact:
media@blueclayhealth.com
Media Contact
Company Name: Blue Clay Health
Contact Person: Chris Riley
Email: Send Email
Country: United States
Website: www.blueclayhealth.com
